Company profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
- CEO
- Mr. Ryan Trasolini
- Headquarters
- Gaithersburg, MD, United States
- Employees
- 2
- IPO date
- Aug 31, 2022
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic